Tirumanisetty Pratyusha, Sotelo Jose William, Disalle Michael, Sharma Meenal
Department of Internal Medicine, Unity Hospital, Greece, New York, USA.
Department of Internal Medicine, Universidad Autonoma Metropolitana - Xochimilco, Coyoacan, Mexico.
BMJ Case Rep. 2019 Jul 30;12(7):e229329. doi: 10.1136/bcr-2019-229329.
A 75-year-old woman with rheumatoid arthritis on rituximab presented with a 1-week history of constipation and abdominal distension. Subsequent workup showed presence of air in the bowel wall without perforation initially. Due to positive blood cultures, worsening leucocytosis and high suspicion for perforation, an exploratory laparotomy was performed revealing necrotic bowel, walled off perforation and abscess. Patient underwent right hemicolectomy with diversion loop ileostomy. Clinicians must recognise that monoclonal antibodies like rituximab can mask signs of inflammation and therefore should maintain a high index of suspicion for intestinal perforation when evaluating patients with minimal symptoms and pneumatosis intestinalis.
一名75岁患类风湿关节炎且正在接受利妥昔单抗治疗的女性,出现了1周的便秘和腹胀病史。随后的检查最初显示肠壁内有气体但无穿孔。由于血培养呈阳性、白细胞增多症恶化且高度怀疑有穿孔,遂进行了剖腹探查术,发现肠坏死、包裹性穿孔和脓肿。患者接受了右半结肠切除术及转流性回肠造口术。临床医生必须认识到,像利妥昔单抗这样的单克隆抗体可能会掩盖炎症迹象,因此在评估症状轻微且有肠壁积气的患者时,应保持高度怀疑肠穿孔的警惕性。